WILLIAMS KRISTEN 4
Research Summary
AI-generated summary
Pacira (PCRX) Chief Admin Officer Kristen Williams Receives Award
What Happened
- Kristen Williams, Chief Administrative Officer of Pacira BioSciences (PCRX), was granted 54,546 restricted stock units (RSUs) on 2026-02-11. The grant is shown at $0.00 per unit (an award/compensation grant), so no cash purchase or sale occurred.
- The filing lists the transaction date as Feb 11, 2026 and was reported on Form 4 filed Feb 13, 2026.
Key Details
- Transaction type: Award/Grant (code A)
- Date of grant: 2026-02-11; Form 4 filed: 2026-02-13 (appears timely under the 2-business-day rule)
- Amount: 54,546 restricted stock units; price reported: $0.00 (no cash exchanged)
- Vesting: RSUs vest in four equal annual installments beginning Feb 15, 2027, contingent on continuous service (each RSU converts to one common share on vesting)
- Shares owned after transaction: not specified in the information provided
- No 10b5-1, tax-withholding sale, or immediate sale noted in this filing
Context
- These RSUs are a compensation award, not an open-market purchase or sale; they generally don’t convey voting rights or settled shares until each tranche vests and is delivered.
- Awards like this are common for executive compensation and reflect grant-based remuneration rather than an insider trading signal.